Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
MINERVA SURGICAL INC (UTRS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/09/2023 |
8-K
| Appointed a new director|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Amended and Restated Certificate of Incorporation of Minerva Surgical, Inc.",
"Amended and Restated Bylaws of Minerva Surgical, Inc.",
"Registration Rights Agreement, by and between Minerva Surgical, Inc., Accelmed Partners II L.P. and New Enterprise Associates 13, L.P",
"Minerva Surgical Closes $30 Million Private Placement of Common Stock Santa Clara, Calif. - February 9, 2023 - Minerva Surgical, Inc. , a women's health company focused on the treatment of Abnormal Uterine Bleeding , announced today that it has closed on the sale of 146,627,565 shares of its common stock in a private placement, led by Accelmed Partners , with participation by New Enterprise Associates, at an offering price of $0.2046 per share. Accelmed is now the controlling stockholder of Minerva Surgical. Gross proceeds of the private placement are approximately $30 million, before deducting placement agent fees and other expenses payable by Minerva Surgical. Piper Sandler acted as sole placement agent for the private placement. Minerva Surgical intends to use the net proceeds from the ..." |
|
|
|